Detalhe da pesquisa
1.
Lymphoblastic Lymphoma: a Concise Review.
Curr Oncol Rep
; 24(1): 1-12, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35059993
2.
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia.
Blood Adv
; 6(6): 1742-1753, 2022 03 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34649276
3.
MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL.
Cancers (Basel)
; 13(9)2021 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33925541
4.
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response.
Haematologica
; 100(8): e299-301, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25820333
5.
Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study.
Hematology
; 24(1): 134-138, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-30355275
6.
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements.
Blood Cancer J
; 14(1): 53, 2024 Mar 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38531834
7.
Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy.
Leuk Res
; 74: 75-79, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30308414
8.
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.
Oncotarget
; 9(18): 14219-14227, 2018 Mar 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29581839
9.
Chronic Myeloid Leukemia With Myelofibrosis-Like Features. Clues of Accelerated Phase?
Int J Surg Pathol
; 27(7): 771-772, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-30813806